Reaction
Retinal Thickening reporting signals
As of the last recalculation, Retinal Thickening appears in 1,214 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 13,498.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 1,020 | 13,498.1 | 15,454.5 |
| Ranibizumab | 93 | 65.0 | 65.2 |
| Aflibercept | 74 | 43.2 | 43.3 |
| Bevacizumab | 124 | 19.0 | 19.0 |